1. Home
  2. SPRC vs CTHR Comparison

SPRC vs CTHR Comparison

Compare SPRC & CTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • CTHR
  • Stock Information
  • Founded
  • SPRC 2004
  • CTHR 1995
  • Country
  • SPRC Israel
  • CTHR United States
  • Employees
  • SPRC 3
  • CTHR N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • CTHR Consumer Specialties
  • Sector
  • SPRC Health Care
  • CTHR Consumer Discretionary
  • Exchange
  • SPRC Nasdaq
  • CTHR Nasdaq
  • Market Cap
  • SPRC 4.8M
  • CTHR 4.1M
  • IPO Year
  • SPRC N/A
  • CTHR 1997
  • Fundamental
  • Price
  • SPRC $0.45
  • CTHR $1.41
  • Analyst Decision
  • SPRC
  • CTHR
  • Analyst Count
  • SPRC 0
  • CTHR 0
  • Target Price
  • SPRC N/A
  • CTHR N/A
  • AVG Volume (30 Days)
  • SPRC 837.4K
  • CTHR 10.4K
  • Earning Date
  • SPRC 02-15-2025
  • CTHR 03-04-2025
  • Dividend Yield
  • SPRC N/A
  • CTHR N/A
  • EPS Growth
  • SPRC N/A
  • CTHR N/A
  • EPS
  • SPRC N/A
  • CTHR N/A
  • Revenue
  • SPRC $1,747,000.00
  • CTHR $23,684,860.00
  • Revenue This Year
  • SPRC N/A
  • CTHR $31.82
  • Revenue Next Year
  • SPRC N/A
  • CTHR N/A
  • P/E Ratio
  • SPRC N/A
  • CTHR N/A
  • Revenue Growth
  • SPRC N/A
  • CTHR N/A
  • 52 Week Low
  • SPRC $0.20
  • CTHR $1.16
  • 52 Week High
  • SPRC $4.29
  • CTHR $4.30
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 43.71
  • CTHR 46.53
  • Support Level
  • SPRC $0.43
  • CTHR $1.28
  • Resistance Level
  • SPRC $0.55
  • CTHR $1.40
  • Average True Range (ATR)
  • SPRC 0.06
  • CTHR 0.07
  • MACD
  • SPRC -0.01
  • CTHR -0.01
  • Stochastic Oscillator
  • SPRC 25.84
  • CTHR 54.17

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About CTHR Charles & Colvard Ltd

Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.

Share on Social Networks: